FDA clears Meditech Spine’s CURE Anterior Cervical Plate system: 5 points

Atlanta-based Meditech Spine received FDA clearance to market its CURE Anterior Cervical Plate system.

Advertisement

Here are five points:

 

1. The CURE ACP system was named for CURE International, an organization helping children with physical disabilities in underserved areas. A portion of all CURE Anterior Cervical Plate sale proceeds will assist CURE International in treating patients.

 

2. The CURE ACP is designed for anterior screw fixation to the C2 to C7 levels of the cervical spine.

 

3. The titanium plate involves a patent-pending, one-step locking mechanism, which stop anchored screws from loosening.

 

4. The system complements the company’s Talos-C (HA) cervical interbody fusion device.

 

5. Craig Humphreys, MD, founder of Kenai Spine in Soldotna, Alaska, co-developed the CURE ACP system. He performed the first procedure with the CURE ACP.

 

More articles on devices:
Dr. Nicholas Theodore to present on the Neuro-Spinal Scaffold at 2016 Congress of Neurological Surgeons Annual Meeting: 4 highlights
Medovex partners with M.Fast Technologies for DenerveX System distribution in Israel: 5 notes
First surgical procedures with Implanet’s Jazz Lock reap success: 5 insights

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.